Guidance for Neurocrine Biosciences Inc. (NBIX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $2.70B – 2.80B | $3.41B | = Maintained | Details |
| 2025 | N/A | N/A | $2.50B – 2.55B | $2.68B | = Maintained | Details |
| 2025 | N/A | N/A | $2.50B – 2.60B | $2.35B | = Maintained | Details |
| 2024 | N/A | N/A | $2.30B – 2.32B | $2.33B | = Maintained | Details |
| 2023 | N/A | N/A | $1.82B – 1.84B | $1.86B | = Maintained | Details |
| 2023 | N/A | N/A | $1.67B – 1.77B | $1.81B | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2013 | ($0.75) – ($0.83) | ($0.55) | N/A | N/A | = Maintained | Details |
| 2012 | ($0.21) – ($0.14) | $0.02 | $40.00M – 45.00M | $51.72M | = Maintained | Details |
| 2011 | $0.62 – $0.71 | $0.37 | $75.00M – 80.00M | $70.50M | = Maintained | Details |
